Prime-Boost Vaccination With BNT162b2 Induces High Neutralizing Activity Against SARS-CoV-2 Variants in Naïve and COVID-19-Convalescent Individuals.

Joanna LuczkowiakNuria LabiodGonzalo RivasMarta RoloFátima LasalaJaime Lora-TamayoMikel Mancheno-LosaDavid RialAlfredo Pérez-RivillaMaría D FolgueiraRafael Delgado

Published in: Open forum infectious diseases (2021)

Vaccination with BNT162b2 induced high levels of neutralization against SARS-CoV-2 VoC in most patients; this is especially beneficial in COVID-19-convalescent individuals.

Keyphrases

sars cov
respiratory syndrome coronavirus
end stage renal disease
coronavirus disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
high glucose